PDS Biotechnology Net Tangible Assets

PDS Biotechnology (PDSB) currently reports a net tangible assets of $-3.6B as of June 2026. That compares with $16M in the prior-year period — down 22529.7% year over year. Use the charts on this page to explore PDS Biotechnology's net tangible assets history and peer comparisons.

PDS Biotechnology's net tangible assets decreased from $16M to $-3.6B — a 22529.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PDS Biotechnology reported $-3.6B in net tangible assets as of June 2026. That compares with $16M in the prior-year period — down 22529.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-3.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PDS Biotechnology, and consider following PDSB for alerts when major investors trade the stock.

PDS Biotechnology is classified in the Healthcare sector. On net tangible assets, it currently shows $-3.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PDSB with unrelated industries.